Search by Drug Name or NDC
NDC 42291-0453-60 cilostazol 100 mg/1 Details
cilostazol 100 mg/1
cilostazol is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is CILOSTAZOL.
MedlinePlus Drug Summary
Cilostazol is used to reduce the symptoms of intermittent claudication (pain in the legs that worsens when walking and improves when resting that is caused by narrowing of the blood vessels that supply blood to the legs). Cilostazol is in a class of medications called platelet-aggregation inhibitors (antiplatelet medications). It works by improving blood flow to the legs.
Related Packages: 42291-0453-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cilostazol
Product Information
| NDC | 42291-0453 |
|---|---|
| Product ID | 42291-453_0e8fc3b1-2e7b-ac30-e063-6394a90ad8cb |
| Associated GPIs | 85155516000330 |
| GCN Sequence Number | 037978 |
| GCN Sequence Number Description | cilostazol TABLET 100 MG ORAL |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 08602 |
| HICL Sequence Number | 017433 |
| HICL Sequence Number Description | CILOSTAZOL |
| Brand/Generic | Generic |
| Proprietary Name | cilostazol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cilostazol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | CILOSTAZOL |
| Labeler Name | AvKARE |
| Pharmaceutical Class | Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077030 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 42291-0453-60 (42291045360)
| NDC Package Code | 42291-453-60 |
|---|---|
| Billing NDC | 42291045360 |
| Package | 60 TABLET in 1 BOTTLE (42291-453-60) |
| Marketing Start Date | 2022-04-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |